Position in TCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,100
+$100 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 60 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aries Wealth Management holds $2,091,330 across 7 Biotechnology names. TCRX ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
25,000 | $953,000 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
4,000 | $676,080 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
605 | $270,156 | |
| 4 | VSTM |
Verastem, Inc.
|
26,249 | $139,119 | |
| 5 | EDIT |
Editas Medicine, Inc.
|
12,500 | $30,875 | |
| 6 | MTVA |
MetaVia Inc.
|
10,000 | $12,000 | |
| 7 | TCRX |
TScan Therapeutics, Inc.
This page
|
10,000 | $10,100 |
All Filings in TCRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,100 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,000 | 10,000 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $18,200 | 10,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,500 | 10,000 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $13,800 | 10,000 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $30,400 | 10,000 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $49,800 | 10,000 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $58,500 | 10,000 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $79,400 | 10,000 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $58,300 | 10,000 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $25,600 | 10,000 | Shares | Sole | 2023-10-19 | |
| No filing history on record for this holder in this stock. | ||||||